We are live on ! Find out more
COLL icon

Collegium Pharmaceutical
COLL

172 hedge funds and large institutions have $734M invested in Collegium Pharmaceutical in 2022 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 63 increasing their positions, 55 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

107% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 14

45% more call options, than puts

Call options by funds: $719K | Put options by funds: $497K

15% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 55

10% more capital invested

Capital invested by funds: $668M → $734M (+$65.6M)

8% more funds holding

Funds holding: 159 → 172 (+13)

4.47% more ownership

Funds ownership: 103.63% → 108.09% (+4.5%)

Holders
172
Holders Change
+13
Holders Change %
+8.18%
% of All Funds
2.71%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
29
Increased
63
Reduced
55
Closed
14
Calls
$719K
Puts
$497K
Net Calls
+$222K
Net Calls Change
+$205K

Top Buyers

1
RCMNY
Rubric Capital Management (New York)
New York
+$7.43M
2
DZ Bank
DZ Bank
Germany
+$5.09M
3
EA
Emerald Advisers
Pennsylvania
+$4.26M
4
Morgan Stanley
Morgan Stanley
New York
+$3.24M
5
State Street
State Street
Massachusetts
+$3.12M

Top Sellers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$26.8M
2
RHJA
Rice Hall James & Associates
California
-$5.04M
3
JG
Jefferies Group
New York
-$3.01M
4
SDIC
South Dakota Investment Council
South Dakota
-$1.42M
5
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$1.17M
Name Holding Trade Value Shares
Change 		Change in
Stake
Federated Hermes
26
Federated Hermes
Pennsylvania
$5.34M -$4.38K -232 -0.1%
Charles Schwab
27
Charles Schwab
California
$5.11M -$266K -14,092 -5%
BGIM
28
Brandywine Global Investment Management
Pennsylvania
$4.94M +$48K +2,538 +1%
N
29
Nuveen
North Carolina
$4.81M -$14.5K -770 -0.3%
Pacer Advisors
30
Pacer Advisors
Pennsylvania
$4.5M +$1.42M +75,090 +51%
SDIC
31
South Dakota Investment Council
South Dakota
$4.46M -$1.42M -75,300 -26%
PPA
32
Parametric Portfolio Associates
Washington
$4.42M +$2.05M +108,549 +100%
CEI
33
Clark Estates Inc
New York
$3.74M – – –
LPL Financial
34
LPL Financial
California
$3.4M +$167K +8,850 +6%
SEI Investments
35
SEI Investments
Pennsylvania
$3.15M +$9.58K +507 +0.3%
D.E. Shaw & Co
36
D.E. Shaw & Co
New York
$2.67M +$220K +11,659 +10%
American Century Companies
37
American Century Companies
Missouri
$2.62M +$506K +26,760 +26%
JIC
38
Johnson Investment Counsel
Ohio
$2.59M +$28.7K +1,520 +1%
JP Morgan Chase
39
JP Morgan Chase
New York
$2.48M -$316K -16,713 -12%
Russell Investments Group
40
Russell Investments Group
United Kingdom
$2.21M +$2.06M +108,803 New
Citadel Advisors
41
Citadel Advisors
Florida
$2.17M +$2.01M +106,525 New
Goldman Sachs
42
Goldman Sachs
New York
$2.05M -$894K -47,317 -32%
Los Angeles Capital Management
43
Los Angeles Capital Management
California
$2.03M +$1.88M +99,519 New
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$1.96M +$104K +5,509 +6%
Victory Capital Management
45
Victory Capital Management
Texas
$1.95M -$45.1K -2,389 -2%
MF
46
Magnetar Financial
Illinois
$1.74M +$1.61M +85,392 New
Legal & General Group
47
Legal & General Group
United Kingdom
$1.65M -$8.09K -428 -0.5%
MPAM
48
Monarch Partners Asset Management
Massachusetts
$1.63M – – –
CSS
49
Cubist Systematic Strategies
Connecticut
$1.52M +$859K +45,470 +155%
ETC
50
Exchange Traded Concepts
Oklahoma
$1.51M +$960K +50,785 +217%
1
2
3 4 5

COLL Hedge Fund Activity: Q1 2022 in Review

172 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q1 2022, worth a combined $734M — up 9.8% from $668M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new COLL positions and 14 closed out — a net gain of 15 holders — while 63 added to existing stakes and 55 trimmed.

The largest buyer was Rubric Capital Management (New York), adding an estimated $7.43M. The largest seller was Janus Henderson Group, cutting an estimated $26.8M.

  • 172 institutional investors held Collegium Pharmaceutical (COLL) as of Q1 2022, up from 159 in Q4 2021.
  • Funds reported $734M of Collegium Pharmaceutical stock for Q1 2022, up 9.8% quarter-over-quarter.
  • 29 funds opened new Collegium Pharmaceutical positions in Q1 2022 and 14 closed out, a net change of +15 holders.
  • The largest Collegium Pharmaceutical buyer in Q1 2022 was Rubric Capital Management (New York), an estimated $7.43M added.
  • The largest Collegium Pharmaceutical seller in Q1 2022 was Janus Henderson Group, an estimated $26.8M sold.

Based on aggregated 13F filings for Q1 2022.